Evaluation of the merits of two drugs-dexmedetomidine and ketamine for day care hysteroscopic procedures

Jayashree Sen, Bitan Sen


Background: The aim was to compare the hemodynamic changes intra operatively and to ascertain the superior efficacy of the study drugs Dexmedetomidine, a highly selective alpha-2-adrenoceptor agonist having sympatholytic, dose dependent sedation, analgesic properties, amnestic effect without respiratory depression and Ketamine, a n-methyl-d-aspartate receptor antagonist, a dissociative sedative hypnotic with potent analgesic properties and marked sympathomimetic effects, have been taken for day care (ambulatory) hysteroscopic procedures. The objectives are to evaluate the requirement of rescue sedative and /or analgesic during the procedure and any complication of the drugs per-operatively.

Methods: About 25 patients in each group in the range of age 20 to 55 years, weight 40-60 kg, height 145-155 cm, ASA I and II were injected with dexmedetomidine (D) 100 µg IV or Ketamine (K) 75 mg IV both over 10 mins at the onset of the procedure. Maintenance of anaesthesia had been done on mask ventilation with 30% oxygen and 70% nitrous oxide.

Results: The demographic data was statistically insignificant. The haemodynamics were stable in the group D, not in group K, ‘p’ value <0.0001. The request for rescue sedation propofol and rescue analgesic fentanyl and the number of top up doses were higher in the group K, p’ value <0.01, statistically highly significant. Group K had suffered more per-operative complications.

Conclusions: Dexmedetomidine for day care hysteroscopic procedures can be the anaesthetic drug of choice.


Dexmedetomidine, Ketamine, Hysteroscopic procedures

Full Text:



Pontusson J, Raess D. The politics of economic crisis in historical-comparative perspective. Swiss Political Sci Rev. 2012;18(4):502-7.

Grewal A. Dexmedetomidine: new avenues. J Anaesthesiol Clin Pharmacol. 2011;27(3):297-302.

Parikh DA, Kolli SN, Karnik HS, Lele SS, Tendolkar BA. A prospective randomized double-blind study comparing dexmedetomidine vs. combination of midazolam-fentanyl for tympanoplasty surgery under monitored anesthesia care. J Anaesthesiol Clin Pharmacol. 2013;29(2):173-8

Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiol. 2000;93(5):1345-9.

Aldrete JA, Kroulik D. A Postanesthetic recovery score. Anesth Analg. 1970;49(6):924-34.

Oto J, Yamamoto K, Koike S, Onodera M, Imanaka H, Nishimura M. Sleep quality of mechanically ventilated patients sedated with dexmedetomidine. Intensive Care Med. 2012;38(12):1982-9.

Lee S, Kim BH, Lim K, Stalker D, Wisemandle W, Shin SG, et al. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J clin Phar Ther. 2012;379(6):698-703.

Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anesthesiol. 2008;21(4):457-61.

Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90(4):834-9.

Taniyama K, Oda H, Okawa K, Himeno K, Shikanai K, Shibutani T. Psychosedation with dex-medetomidine hydrochloride during minor oral surgery. Anesth Prog. 2009;56(3):75-80.

Parikh DA, Kolli SN, Karnik HS, Lele SS, Tendolkar BA. A prospective randomized double-blind study comparing dexmedetomidine vs. combination of midazolam-fentanyl for tympanoplasty surgery under monitored anesthesia care. J Anaesthesiol Clin Pharmacol. 2013;29(2):173-8.

Alhashemi JA. Dexmedetomidine vs. midazolam for monitored anaesthesia care during cataract surgery. Brit J Anaesth. 2006;96(6):722-6.

Karaaslan K, Yilmaz F, Gulcu N, Colak C, Sereflican M, Kocoglu H. Comparison of dexmedetomidine and midazolam for monitored anesthesia care combined with tramadol via patient-controlled analgesia in endoscopic nasal surgery: A prospective, randomized, double-blind, clinical study. Curr Ther Res Clin Exp. 2007;68(2):69-81.

Gerlach AT, Dasta JF. Dexmedetomidine: An updated review. Ann Pharmacother. 2007;41(2):245-52.

Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG. A comparison of Dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia. 2007;62(11):1132-8.

Na HS, Song IA, Park HS, Hwang JW, Do SH, Kim CS. Dexmedetomidine is effective for monitored anesthesia care in outpatients undergoing cataract surgery. Korean J Anesthesiol. 2011;61(6):453-9

Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14(1):13-21.

Abdellatif AA, Elkabarity RH, Hamdy TA. Dexmedetomidine vs. midazolam sedation in middle ear surgery under local anesthesia: Effect on surgical field and patient satisfaction. Egypt J Anaesth. 2012;28(2):117-23.

Ghali A, Mahfouz AK, Ihanamäki T. Dexmedetomidine versus propofol for sedation in patients undergoing vitreoretinal surgery under sub-Tenon's anesthesia. Saudi J Anaesth. 2011;5(1):36-41.

Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95(2):461-6.

Takimoto K, Ueda T, Shimamoto F, Kojima Y, Fujinaga Y, Kashiwa A. Sedation with dexmedetomidine hydrochloride during endoscopic submucosal dissection of gastric cancer. Dig Endosc. 2011;23(2):176-81.

Gurbet A, Mogol BE, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth. 2006;53(7):646-52

Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90(3):699-705.

Tanskanen PE, Kyttä JV, Randell TT, Aantaa RE. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Brit J Anaesth. 2006;97(5):658-65.

Verma R, Gupta R, Bhatia VK, Bogra J, Agarwal SP. Dexmedetomidine and propofol for monitored anesthesia care in the middle ear surgery. Indian J Otol. 2014;20(2):70.

Warncke T, Stubhaug A, Jorum E. Ketamine. An NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 1997;72:99(1-2):99-106.

White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiol. 1982;56:119-36.

Tobias JD, Leder M. Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anaesth. 2011;5(4):395-410.

Miner JR, Burton JH. Clinical practice advisory: Emergency department procedural sedation with propofol. Ann Emerg Med. 2007;50(2):182-7.

Brunton L, Blumenthal D, Buxton I, Parker K. Goodman and Gilman’s Manual of Pharmacology and therapeutics. 2007:227-31.